Tucanat 150 mg Tablets for New York Oncology Buyers
Tucanat 150 mg is an oral oncology medicine containing Tucatinib 150 mg. For pharmaceutical importers, distributors, hospitals and oncology procurement teams searching for a Tucanat 150 mg Tablets supplier in New York City, understanding the product specification, therapeutic category, pack configuration and sourcing requirements is important before placing an enquiry. Tucatinib is a targeted medicine that inhibits HER2 tyrosine kinase activity. It is used in defined HER2-positive cancer treatment settings under specialist medical supervision.
Tucanat 150 mg Product Details
| Product Information | Details |
|---|---|
| Brand | Tucanat |
| Generic Name | Tucatinib |
| Strength | 150 mg |
| Dosage Form | Tablets |
| Route | Oral |
| Pack Shown | 60 Tablets |
| Therapeutic Category | Targeted Oncology Therapy |
| Prescription Status | Prescription medicine |
What Is Tucatinib 150 mg Used For?
Tucatinib is a HER2-directed tyrosine kinase inhibitor. In the United States, tucatinib is indicated in combination with other medicines for defined groups of patients with advanced or metastatic HER2-positive breast cancer. It also has an indication for a specified group of patients with HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer. Treatment selection depends on factors such as HER2 status, previous therapy, disease characteristics and the patient's clinical condition.
What New York Buyers Usually Check Before Procurement
A professional buyer searching for Tucatinib 150 mg Tablets in New York will generally need more information than a product price.
Common procurement checks include:
- Correct generic name and strength
- Brand and manufacturer details
- Available pack size
- Batch number
- Manufacturing and expiry dates
- Required commercial quantity
- Product documentation availability
- Export packaging
- Shipping feasibility
- Destination import requirements
Providing these details during the initial enquiry can make the procurement process more efficient.
Tucatinib 150 mg Export Supply from India
Ernest Oncology supports international enquiries for specialized oncology medicines, including Tucanat 150 mg Tablets export from India.
Supply enquiries may be received from licensed pharmaceutical distributors, wholesalers, importers, hospital procurement teams and other authorized healthcare organizations.
Storage and Handling
Tucanat should be stored and handled according to the manufacturer's instructions. Pharmaceutical buyers should also maintain appropriate storage conditions during transportation and distribution. The original packaging, batch information and expiry details should be checked when receiving pharmaceutical stock.
Important Safety Information
Tucatinib is a prescription anticancer medicine and should only be used under the supervision of a qualified oncology professional. Important safety considerations associated with tucatinib include diarrhea and hepatotoxicity. Drug interactions and individual patient factors may also affect treatment.
Ernest Oncology provides product and international sourcing information for professional pharmaceutical enquiries. Product availability, documentation, packaging and shipment requirements should be verified for each order rather than assumed from previously published information.
Tucanat 150 mg Tablets New York City, Tucanat supplier New York, Tucatinib 150 mg supplier New York, Tucatinib Tablets New York, oncology medicine supplier New York, Tucatinib exporter India USA.
FAQs – Tucanat 150 mg New York City
Contact Ernest Oncology
Official Websites
🌐 www.oncologymedicinesupplier.com
WhatsApp
📱 +91 93599 02383
Chat with Us on WhatsApp
💬 https://wa.me/919359902383
